850 followers
@n8pennell @StephenVLiu @FDAOncology One option we may see in the clinic soon, may be EGFR/FAKi. To this point, FAKi Defactinib has been dosed continuously, now with EGFRi, it would be interesting to see FAKi added to combo in a cyclic pulsatile dosing mod